2021 Annual Meeting
Interested in attending the 2021 ITSCC Member Meeting? Register here.
ITSCC Member Meeting
Saturday, March 20, 2021
|12:00 – 12:05 pm||Opening remarks by ITSCC President, Sarah Arron, MD|
|12:05 – 12:50 pm||Abstracts and Educational Session|
|12:50 – 1:10 pm||Business Meeting|
|1:10 – 1:55 pm||Keynote speaker - Oscar Colegio Memorial Lecture
Dr. Catherine Harwood, MA, PhD, FRCP; Professor of Dermatology, Royal London Hospital and Blizzard Institute, Queen Mary University of London
|1:55 – 2:05 pm||NCCN Update, Chrys Schmults, MD|
|2:05 - 2:40 pm||Tumor Board|
|2:40 – 2:45 pm||Closing Remarks|
|2:45 – 3:15 pm||Zoom Pictionary|
Castle Biosciences, Inc.
820 S. Friendswood Dr., Suite 201
Friendswood, TX 77546
P (866) 788-9007
Castle Biosciences is a skin cancer diagnostics company focused on providing physicians and patients with personalized, clinically actionable genomic information enabling more accurate treatment plan decisions. From its formation in 2008, Castle Biosciences has applied emerging artificial intelligence techniques in molecular diagnostics to improve patient care and outcomes. Our DecisionDx family of molecular diagnostic tests have the ability to meaningfully impact how cancers are diagnosed and managed (https://castletestinfo.com).
1 DNA Way
South San Francisco, CA 94080
P (650) 255-2169
For more than 40 years, we've been following the science, seeking solutions to unmet medical needs. As a proud member of the Roche Group, we make medicines to treat patients with serious medical conditions.
Your tax-deductible donation supports the education and research of physicians and scientists committed to improving the quality of life of organ transplant recipients. If you are unable to donate online or require other information to make a gift through a trust or other source, email firstname.lastname@example.org for additional assistance. ITSCC's federal tax ID is 43-1964114.
ITSCC is a nonprofit 501(c)(3) organization, and has received support through unrestricted educational grants from pharmaceutical companies and donations of time and funds from physicians, researchers, transplant patients and their families.